Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion type Assertion NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_head.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion description "[Although the frequency of mutations in the p16/CDKN2 gene has been detected in approximately 30% of non-small cell lung cancer, loss of heterozygosity on 9p has been observed in greater than 70% of non-small cell lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_provenance.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion evidence source_evidence_literature NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_provenance.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion SIO_000772 8988029 NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_provenance.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion wasDerivedFrom befree-20140225 NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_provenance.
- NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_assertion wasGeneratedBy ECO_0000203 NP540055.RAXnJzBK_Vj9UWJNsYCQhSUcbMfymGK2clQhMRbtfs6FQ130_provenance.